Human Papillomavirus (HPV) remains one of the most common viral infections worldwide and is strongly associated with cervical cancer. While preventive HPV vaccines have transformed public health strategies, effective treatment options for existing HPV infections and precancerous cervical lesions continue to be an active area of research.
A recent study from Mexico has attracted significant attention after reporting remarkably high HPV clearance rates following photodynamic therapy (PDT), a treatment that combines a photosensitizing agent with a specific wavelength of light to destroy abnormal cells and microorganisms.
What Did the Study Investigate?
Researchers evaluated the effectiveness of photodynamic therapy in women diagnosed with HPV infection and Cervical Intraepithelial Neoplasia grade I (CIN I), an early-stage precancerous cervical lesion.
The study, titled Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I, was published in Photochemistry and Photobiology in 2023.
A total of 29 women participated in the study. Researchers assessed HPV clearance, regression of cervical lesions, and changes in cervical microbiota following PDT treatment.
Key Findings
According to the researchers, six months after photodynamic therapy :
* HPV infection was eliminated in 100% of women who had HPV infection without associated CIN I lesions.
* Among women with both HPV infection and CIN I, 64.3% showed elimination of HPV and lesion improvement.
* In women with CIN I alone, lesion remission was observed in 57.2% of cases.
* The therapy also reduced certain pathogenic microorganisms, including Chlamydia trachomatis and Candida albicans, while largely preserving normal cervical microbial flora.
These findings suggest that photodynamic therapy may have both antiviral and antimicrobial effects in selected patients.
What Is Photodynamic Therapy?
Photodynamic therapy (PDT) is a minimally invasive treatment approach that involves three key components:
1. A photosensitizing drug.
2. Light of a specific wavelength.
3. Oxygen present in tissues.
When activated by light, the photosensitizer generates reactive oxygen species that can damage abnormal cells and infectious agents. Researchers have explored PDT in dermatology, oncology, and gynecology for several years.
Unlike surgical procedures, PDT aims to preserve cervical tissue, making it particularly attractive for women who wish to maintain fertility.
Why Are Researchers Interested in PDT for HPV?
Persistent infection with high-risk HPV strains is a major risk factor for cervical cancer development. Current management of cervical precancerous lesions often involves surveillance, ablative procedures, or excisional treatments depending on lesion severity.
Scientists are exploring whether PDT can :
* Eliminate HPV infection.
* Promote regression of cervical lesions.
* Reduce the need for invasive procedures.
* Preserve reproductive function.
Several previous studies have reported encouraging outcomes with PDT in HPV-associated cervical lesions, although results vary across populations and treatment protocols.
Evidence Beyond the Mexican Study
The Mexican study is not the only investigation examining PDT in HPV-related cervical disease.
A 2021 study involving women with HSIL/CIN2 reported complete histological remission in approximately 77.8% of patients one year after treatment with 5-aminolevulinic acid photodynamic therapy. Researchers also observed HPV remission in a substantial proportion of participants while reporting mostly mild adverse effects.
In addition, a 2018 systematic review and meta-analysis concluded that photodynamic therapy may improve outcomes in cervical intraepithelial neoplasia and HPV infection, although researchers emphasized the need for further high-quality clinical trials.
More recently, a 2026 study involving 811 women reported overall HPV clearance rates exceeding 90% following PDT, highlighting growing scientific interest in this treatment modality. However, researchers also noted that factors such as multiple HPV genotype infections could influence treatment success.
Important Limitations
Although the results appear promising, several limitations must be considered before drawing broad conclusions.
Small Sample Size
The Mexican study included only 29 participants. Such a small sample limits the ability to generalize findings to larger populations.
Lack of Large Randomized Trials
The study was not a large multicenter randomized controlled trial, which remains the gold standard for evaluating treatment effectiveness.
Not a Universal “Cure”
Some social media posts have described the findings as a definitive cure for HPV. However, the study's results apply only to a small group of patients under specific clinical conditions. Additional research is required before PDT can be considered a standard treatment for HPV infection.
Long-Term Outcomes Need Evaluation
Researchers continue to investigate whether HPV clearance achieved through PDT remains durable over many years and whether it significantly reduces cervical cancer risk in the long term.
The Future of HPV Treatment
The growing body of research suggests that photodynamic therapy may emerge as a valuable organ-preserving option for selected patients with HPV-associated cervical abnormalities. If larger clinical trials confirm current findings, PDT could potentially become an important addition to cervical disease management strategies.
However, It is emphasized that HPV vaccination, regular cervical screening, and appropriate medical follow-up remain the most effective approaches for preventing cervical cancer today.
Reference
López-Cárdenas MT, Ramón-Gallegos E, et al. *Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I.* Photochemistry and Photobiology. 2023. PMID: 36773299. Available through PubMed: https://pubmed.ncbi.nlm.nih.gov/36773299/
- Rajesh Vagh
PharmaTutor Edu Labs
